Stock Earnings

Question 1

What are Shanghai Henlius Biotech Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Shanghai Henlius Biotech Inc has a total asset of $10,597, Net profit of $820

Question 2

What are the key financial ratios for SGBCF?

Accepted Answer

Shanghai Henlius Biotech Inc's Current ratio is 1.39, has a Net margin is 14.32, sales per share of $10.53.

Question 3

How is Shanghai Henlius Biotech Inc's revenue broken down by segment or geography?

Accepted Answer

Shanghai Henlius Biotech Inc largest revenue segment is Biopharmaceutical, at a revenue of 6,206,584,358 in the most earnings release.For geography, China is the primary market for Shanghai Henlius Biotech Inc, at a revenue of 5,471,102,167.

Question 4

Is Shanghai Henlius Biotech Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Shanghai Henlius Biotech Inc has a net profit of $820

Question 5

Does Shanghai Henlius Biotech Inc have any liabilities?

Accepted Answer

yes, Shanghai Henlius Biotech Inc has liability of 7,583

Question 6

How many outstanding shares for Shanghai Henlius Biotech Inc?

Accepted Answer

Shanghai Henlius Biotech Inc has a total outstanding shares of 543.49

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	5,797	5,724	5,394	3,214	1,682	587
Revenue Growth (YoY)	3%	6%	68%	91%	187%	552%
Cost of Revenue	1,404	1,539	1,476	844	522	182
Gross Profit	4,393	4,184	3,918	2,370	1,159	405
Selling, General & Admin	2,401	2,283	2,168	1,404	801	436
Research & Development	1,138	1,035	1,118	1,394	1,023	894
Operating Expenses	3,462	3,245	3,245	2,994	2,034	1,362
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	843	845	569	-693	-956	-993
Income Tax Expense	19	25	23	1	27	0
Net Income	824	820	546	-695	-984	-993
Net Income Growth	19%	50%	-179%	-28.99%	-1%	13%
Shares Outstanding (Diluted)	543.49	543.49	543.37	542.02	538.83	529.57
Shares Change (YoY)	0%	0%	0%	1%	2%	7%
EPS (Diluted)	1.51	1.5	1	-1.28	-1.82	-1.87
EPS Growth	19%	50%	-178%	-30%	-3%	7%
Free Cash Flow	753	404	36	-383	-1,040	-1,166
Free Cash Flow Per Share	1.38	0.74	0.06	-0.7	-1.93	-2.2
Gross Margin	75.78%	73.09%	72.63%	73.73%	68.9%	68.99%
Operating Margin	16.06%	16.38%	12.47%	-19.41%	-51.96%	-163.03%
Profit Margin	14.21%	14.32%	10.12%	-21.62%	-58.5%	-169.16%
Free Cash Flow Margin	12.98%	7.05%	0.66%	-11.91%	-61.83%	-198.63%
EBITDA	1,353	1,312	1,032	-347	-674	-822
EBITDA Margin	23.33%	22.92%	19.13%	-10.79%	-40.07%	-140.03%
D&A For EBITDA	422	374	359	277	200	135
EBIT	931	938	673	-624	-874	-957
EBIT Margin	16.06%	16.38%	12.47%	-19.41%	-51.96%	-163.03%
Effective Tax Rate	2.25%	2.95%	4.04%	-0.14%	-2.82%	0%

Shanghai Henlius Biotech Inc (SGBCF) Price

SGBCF Stock Price Chart

SGBCF Income

Follow-Up Questions